Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-25-040671
Filing Date
2025-11-06
Accepted
2025-11-06 08:22:15
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 ny20058362x1_424b5.htm 424B5 491542
2 logo_ocuphire.jpg GRAPHIC 60098
3 logo_opusgenetics.jpg GRAPHIC 36917
4 logo_opusgeneticsx1.jpg GRAPHIC 45738
  Complete submission text file 0001140361-25-040671.txt   689007
Mailing Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713
Business Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713 248-681-9815
Opus Genetics, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-276462 | Film No.: 251456311
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)